Phillips, Elizabeth H.
Lannon, Michelle M.
Lopes, Andre
Chadwick, Humra
Jones, Gail
Sieniawski, Michal
Davies, Andrew
Wood, Katrina
Clifton-Hadley, Laura
Smith, Paul
Lawrie, Anthony
Chadwick, Nick
Lennard, Anne L.
Funding for this research was provided by:
Cancer Research UK (CRUK) (C12372/A4755)
Article History
Received: 16 May 2018
Revised: 29 June 2018
Accepted: 7 July 2018
First Online: 13 August 2018
Change Date: 6 March 2019
Change Type: Update
Change Date: 12 March 2019
Change Type: Correction
Change Details: In the original version of this manuscript, the mention of ‘ifosfamide 1500mg/m2 days 1-3’ should in fact read ‘ifosfamide 1500mg/m2 bd days 1-3’. This has now been updated in the original version of the manuscript.
Change Details: In the original version of this article, the mention of ‘ifosfamide 1500 mg/m Superscript removed days 1–3’ should, in fact, read ‘ifosfamide 1500 mg/m Superscript removed bd days 1–3’. This has now been updated in the original version of the article.
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.